Back
Illumina Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
44
ILMN
Illumina
Last Price:
131.14
Seasonality Move:
-1.84%
Sell
49
RARE
Ultragenyx Pharmaceutical
Last Price:
58.74
Seasonality Move:
-0.7%
Sell
44
Illumina (ILMN)
is a Sell
Is Illumina a Buy, Sell or Hold?
- The current Illumina [ILMN] share price is $134.30. The Score for ILMN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- ILMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $58.77. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $58.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
ILMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.57 | Buy |
| Relative Strength Index (14 RSI): | 62.92 | Buy |
| Chaikin Money Flow: | -591583 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (126.56 - 132.96) | Buy |
| Bollinger Bands (100): | (108.08 - 126.76) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | -154927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.53 - 58.27) | Buy |
| Bollinger Bands (100): | (39.73 - 52.87) | Buy |
ILMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.67 | Buy |
| 20-day SMA: | 129.2 | Buy |
| 50-day SMA: | 124.68 | Buy |
| 200-day SMA: | 125.43 | Buy |
| 8-day EMA: | 130 | Buy |
| 20-day EMA: | 128.55 | Buy |
| 50-day EMA: | 124.87 | Buy |
| 200-day EMA: | 128.65 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.87 | Buy |
| 20-day SMA: | 57.08 | Buy |
| 50-day SMA: | 51.49 | Buy |
| 200-day SMA: | 46.42 | Buy |
| 8-day EMA: | 57.94 | Buy |
| 20-day EMA: | 56.47 | Buy |
| 50-day EMA: | 52.53 | Buy |
| 200-day EMA: | 46.74 | Buy |
Illumina Earnings Growth & ILMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.73 per share, an increase next quarter of $0.27 per share, an increase this year of $2.78 per share, and an increase next year of $0.54 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Illumina Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||